Developer of an artificial intelligence-enabled platform designed to advance synthetic lethal oncology. The company's platform identifies novel synthetic lethal targets and biomarkers and develops small-molecule therapeutic drug candidates, enabling clients to discover and develop treatments for cancer.
Developer of an artificial intelligence-based healthcare technology designed to assist clinicians in detecting and diagnosing cancer. The company's technology develops imaging and multi-omics biomarkers and reporting tools using artificial intelligence and MRI, to support cancer screening and diagnosis, enabling clinicians and physicians to make cancer detection accurate, accessible, cost-effective, and quick.
Developer of a risk detection platform designed to provide artificial intelligence-driven services for businesses. The company's platform offers machine learning technology to help clients detect risks of emerging legal disputes with customers, employees, and other stakeholders across different communication channels, enabling businesses to focus their valuable time, energy, and resources on building and cultivating relationships with all of their stakeholders.